aluates Reports

$ 0.0

Automative

Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Research Report 2024

Published Date: October 2024

Report Code: QYRE-Auto-28S18151

BUY CHAPTERS

Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Research Report 2024

Code: QYRE-Auto-28S18151

Report

October 2024

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Companies

Medicilon

Creative Peptides

PeptiStar

BOCSCI Inc.

Huateng Pharma

CPC Scientific Inc.

Porton

Viva Biotech

Center Laboratories Inc

Jiuzhou Pharmaceutical

WUXIAPP

Taichu Group

PharosGen

Peptide-Drug Conjugates(PDCs) CDMO Service Market

Peptide-drug conjugates (PDCs) consist of a cytotoxic payload, a homing peptide, and a linker between the peptide and the cytotoxic payload. Following antibody-drug conjugates, they are the next generation of targeted therapeutics with enhanced cell permeability and better drug selectivity. They offer excellent opportunities for targeting cancer, metabolic diseases, and more. Although the potential is huge, development challenges such as poor stability, poor targeting, and potential payload toxicity may slow down preclinical and clinical development processes. CDMO services refer to pharmaceutical companies and biotechnology companies outsourcing the research and development and production of their drugs or biologics to professional CDMO companies. These CDMO companies provide a range of services, including but not limited to drug synthesis, chemical and biological analysis, formulation development, clinical production, and commercial production. The core of CDMO services lies in its customization and specialization capabilities, which can meet the specific needs of different customers at different stages.

The global Peptide-Drug Conjugates(PDCs) CDMO Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.

North American market for Peptide-Drug Conjugates(PDCs) CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

Asia-Pacific market for Peptide-Drug Conjugates(PDCs) CDMO Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The global market for Peptide-Drug Conjugates(PDCs) CDMO Service in SME Pharmaceutical Company is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.

The major global companies of Peptide-Drug Conjugates(PDCs) CDMO Service include WUXIAPP, Medicilon, Creative Peptides, Peptistar, BOCSCI Inc, HUATENG PHARMA, CPC Scientific Inc, Porton, VIVA Biotech, Taichu Group, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Peptide-Drug Conjugates(PDCs) CDMO Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Peptide-Drug Conjugates(PDCs) CDMO Service.

The Peptide-Drug Conjugates(PDCs) CDMO Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Peptide-Drug Conjugates(PDCs) CDMO Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Peptide-Drug Conjugates(PDCs) CDMO Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Peptide-Drug Conjugates(PDCs) CDMO Service Market Report

Report Metric	Details
Report Name	Peptide-Drug Conjugates(PDCs) CDMO Service Market
Segment by Type	Therapeutic Diagnostic
Segment by Application	SME Pharmaceutical Company Large Pharmaceutical Company
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	WUXIAPP, Medicilon, Creative Peptides, Peptistar, BOCSCI Inc, HUATENG PHARMA, CPC Scientific Inc, Porton, VIVA Biotech, Taichu Group, PharosGen, CENTER LABORATORIES, INC, JIUZHOU Pharmaceutical
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Peptide-Drug Conjugates(PDCs) CDMO Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Peptide-Drug Conjugates(PDCs) CDMO Service Market report?

Ans: The main players in the Peptide-Drug Conjugates(PDCs) CDMO Service Market are WUXIAPP, Medicilon, Creative Peptides, Peptistar, BOCSCI Inc, HUATENG PHARMA, CPC Scientific Inc, Porton, VIVA Biotech, Taichu Group, PharosGen, CENTER LABORATORIES, INC, JIUZHOU Pharmaceutical

What are the Application segmentation covered in the Peptide-Drug Conjugates(PDCs) CDMO Service Market report?

Ans: The Applications covered in the Peptide-Drug Conjugates(PDCs) CDMO Service Market report are SME Pharmaceutical Company, Large Pharmaceutical Company

What are the Type segmentation covered in the Peptide-Drug Conjugates(PDCs) CDMO Service Market report?

Ans: The Types covered in the Peptide-Drug Conjugates(PDCs) CDMO Service Market report are Therapeutic, Diagnostic

Recommended Reports

CDMO Services

Conjugate Therapeutics

Peptide Drugs & CDMO

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Therapeutic

1.2.3 Diagnostic

1.3 Market by Application

1.3.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 SME Pharmaceutical Company

1.3.3 Large Pharmaceutical Company

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Perspective (2019-2030)

2.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Growth Trends by Region

2.2.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Region (2019-2024)

2.2.3 Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Region (2025-2030)

2.3 Peptide-Drug Conjugates(PDCs) CDMO Service Market Dynamics

2.3.1 Peptide-Drug Conjugates(PDCs) CDMO Service Industry Trends

2.3.2 Peptide-Drug Conjugates(PDCs) CDMO Service Market Drivers

2.3.3 Peptide-Drug Conjugates(PDCs) CDMO Service Market Challenges

2.3.4 Peptide-Drug Conjugates(PDCs) CDMO Service Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Revenue

3.1.1 Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Revenue (2019-2024)

3.1.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Players (2019-2024)

3.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue

3.4 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Concentration Ratio

3.4.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue in 2023

3.5 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service Head office and Area Served

3.6 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Product and Application

3.7 Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Peptide-Drug Conjugates(PDCs) CDMO Service Breakdown Data by Type

4.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Type (2019-2024)

4.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Type (2025-2030)

5 Peptide-Drug Conjugates(PDCs) CDMO Service Breakdown Data by Application

5.1 Global Peptide-Drug Conjugates(PDCs) CDMO Service Historic Market Size by Application (2019-2024)

5.2 Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2019-2030)

6.2 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024)

6.4 North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2019-2030)

7.2 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024)

7.4 Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2019-2030)

8.2 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2019-2024)

8.4 Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2019-2030)

9.2 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024)

9.4 Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (2019-2030)

10.2 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024)

10.4 Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 WUXIAPP

11.1.1 WUXIAPP Company Details

11.1.2 WUXIAPP Business Overview

11.1.3 WUXIAPP Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.1.4 WUXIAPP Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.1.5 WUXIAPP Recent Development

11.2 Medicilon

11.2.1 Medicilon Company Details

11.2.2 Medicilon Business Overview

11.2.3 Medicilon Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.2.4 Medicilon Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.2.5 Medicilon Recent Development

11.3 Creative Peptides

11.3.1 Creative Peptides Company Details

11.3.2 Creative Peptides Business Overview

11.3.3 Creative Peptides Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.3.4 Creative Peptides Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.3.5 Creative Peptides Recent Development

11.4 Peptistar

11.4.1 Peptistar Company Details

11.4.2 Peptistar Business Overview

11.4.3 Peptistar Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.4.4 Peptistar Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.4.5 Peptistar Recent Development

11.5 BOCSCI Inc

11.5.1 BOCSCI Inc Company Details

11.5.2 BOCSCI Inc Business Overview

11.5.3 BOCSCI Inc Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.5.4 BOCSCI Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.5.5 BOCSCI Inc Recent Development

11.6 HUATENG PHARMA

11.6.1 HUATENG PHARMA Company Details

11.6.2 HUATENG PHARMA Business Overview

11.6.3 HUATENG PHARMA Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.6.4 HUATENG PHARMA Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.6.5 HUATENG PHARMA Recent Development

11.7 CPC Scientific Inc

11.7.1 CPC Scientific Inc Company Details

11.7.2 CPC Scientific Inc Business Overview

11.7.3 CPC Scientific Inc Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.7.4 CPC Scientific Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.7.5 CPC Scientific Inc Recent Development

11.8 Porton

11.8.1 Porton Company Details

11.8.2 Porton Business Overview

11.8.3 Porton Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.8.4 Porton Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.8.5 Porton Recent Development

11.9 VIVA Biotech

11.9.1 VIVA Biotech Company Details

11.9.2 VIVA Biotech Business Overview

11.9.3 VIVA Biotech Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.9.4 VIVA Biotech Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.9.5 VIVA Biotech Recent Development

11.10 Taichu Group

11.10.1 Taichu Group Company Details

11.10.2 Taichu Group Business Overview

11.10.3 Taichu Group Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.10.4 Taichu Group Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.10.5 Taichu Group Recent Development

11.11 PharosGen

11.11.1 PharosGen Company Details

11.11.2 PharosGen Business Overview

11.11.3 PharosGen Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.11.4 PharosGen Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.11.5 PharosGen Recent Development

11.12 CENTER LABORATORIES, INC

11.12.1 CENTER LABORATORIES, INC Company Details

11.12.2 CENTER LABORATORIES, INC Business Overview

11.12.3 CENTER LABORATORIES, INC Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.12.4 CENTER LABORATORIES, INC Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.12.5 CENTER LABORATORIES, INC Recent Development

11.13 JIUZHOU Pharmaceutical

11.13.1 JIUZHOU Pharmaceutical Company Details

11.13.2 JIUZHOU Pharmaceutical Business Overview

11.13.3 JIUZHOU Pharmaceutical Peptide-Drug Conjugates(PDCs) CDMO Service Introduction

11.13.4 JIUZHOU Pharmaceutical Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

11.13.5 JIUZHOU Pharmaceutical Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Companies

Medicilon

Creative Peptides

PeptiStar

BOCSCI Inc.

Huateng Pharma

CPC Scientific Inc.

Porton

Viva Biotech

Center Laboratories Inc

Jiuzhou Pharmaceutical

WUXIAPP

Taichu Group

PharosGen

List of Tables

Table 1. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Therapeutic

Table 3. Key Players of Diagnostic

Table 4. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2019-2024)

Table 8. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2025-2030)

Table 10. Peptide-Drug Conjugates(PDCs) CDMO Service Market Trends

Table 11. Peptide-Drug Conjugates(PDCs) CDMO Service Market Drivers

Table 12. Peptide-Drug Conjugates(PDCs) CDMO Service Market Challenges

Table 13. Peptide-Drug Conjugates(PDCs) CDMO Service Market Restraints

Table 14. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Players (2019-2024)

Table 16. Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service as of 2023)

Table 17. Ranking of Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue (CR5 and HHI) & (2019-2024)

Table 19. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Headquarters and Area Served

Table 20. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Product and Application

Table 21. Global Key Players of Peptide-Drug Conjugates(PDCs) CDMO Service, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Type (2019-2024)

Table 25. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Type (2025-2030)

Table 27. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Application (2019-2024)

Table 29. Global Peptide-Drug Conjugates(PDCs) CDMO Service Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global Peptide-Drug Conjugates(PDCs) CDMO Service Revenue Market Share by Application (2025-2030)

Table 31. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Country (2025-2030) & (US$ Million)

Table 46. WUXIAPP Company Details

Table 47. WUXIAPP Business Overview

Table 48. WUXIAPP Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 49. WUXIAPP Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 50. WUXIAPP Recent Development

Table 51. Medicilon Company Details

Table 52. Medicilon Business Overview

Table 53. Medicilon Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 54. Medicilon Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 55. Medicilon Recent Development

Table 56. Creative Peptides Company Details

Table 57. Creative Peptides Business Overview

Table 58. Creative Peptides Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 59. Creative Peptides Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 60. Creative Peptides Recent Development

Table 61. Peptistar Company Details

Table 62. Peptistar Business Overview

Table 63. Peptistar Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 64. Peptistar Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 65. Peptistar Recent Development

Table 66. BOCSCI Inc Company Details

Table 67. BOCSCI Inc Business Overview

Table 68. BOCSCI Inc Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 69. BOCSCI Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 70. BOCSCI Inc Recent Development

Table 71. HUATENG PHARMA Company Details

Table 72. HUATENG PHARMA Business Overview

Table 73. HUATENG PHARMA Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 74. HUATENG PHARMA Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 75. HUATENG PHARMA Recent Development

Table 76. CPC Scientific Inc Company Details

Table 77. CPC Scientific Inc Business Overview

Table 78. CPC Scientific Inc Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 79. CPC Scientific Inc Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 80. CPC Scientific Inc Recent Development

Table 81. Porton Company Details

Table 82. Porton Business Overview

Table 83. Porton Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 84. Porton Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 85. Porton Recent Development

Table 86. VIVA Biotech Company Details

Table 87. VIVA Biotech Business Overview

Table 88. VIVA Biotech Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 89. VIVA Biotech Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 90. VIVA Biotech Recent Development

Table 91. Taichu Group Company Details

Table 92. Taichu Group Business Overview

Table 93. Taichu Group Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 94. Taichu Group Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 95. Taichu Group Recent Development

Table 96. PharosGen Company Details

Table 97. PharosGen Business Overview

Table 98. PharosGen Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 99. PharosGen Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 100. PharosGen Recent Development

Table 101. CENTER LABORATORIES, INC Company Details

Table 102. CENTER LABORATORIES, INC Business Overview

Table 103. CENTER LABORATORIES, INC Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 104. CENTER LABORATORIES, INC Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 105. CENTER LABORATORIES, INC Recent Development

Table 106. JIUZHOU Pharmaceutical Company Details

Table 107. JIUZHOU Pharmaceutical Business Overview

Table 108. JIUZHOU Pharmaceutical Peptide-Drug Conjugates(PDCs) CDMO Service Product

Table 109. JIUZHOU Pharmaceutical Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024) & (US$ Million)

Table 110. JIUZHOU Pharmaceutical Recent Development

Table 111. Research Programs/Design for This Report

Table 112. Key Data Information from Secondary Sources

Table 113. Key Data Information from Primary Sources

Table 114. Authors List of This Report

List of Figures

Figure 1. Peptide-Drug Conjugates(PDCs) CDMO Service Picture

Figure 2. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 3. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Type: 2023 VS 2030

Figure 4. Therapeutic Features

Figure 5. Diagnostic Features

Figure 6. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size by Application (2024-2030) & (US$ Million)

Figure 7. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Application: 2023 VS 2030

Figure 8. SME Pharmaceutical Company Case Studies

Figure 9. Large Pharmaceutical Company Case Studies

Figure 10. Peptide-Drug Conjugates(PDCs) CDMO Service Report Years Considered

Figure 11. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region: 2023 VS 2030

Figure 14. Global Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Players in 2023

Figure 15. Global Top Peptide-Drug Conjugates(PDCs) CDMO Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Peptide-Drug Conjugates(PDCs) CDMO Service as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by Peptide-Drug Conjugates(PDCs) CDMO Service Revenue in 2023

Figure 17. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2019-2030)

Figure 19. United States Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2019-2030)

Figure 23. Germany Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Region (2019-2030)

Figure 31. China Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2019-2030)

Figure 39. Mexico Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa Peptide-Drug Conjugates(PDCs) CDMO Service Market Share by Country (2019-2030)

Figure 43. Turkey Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. UAE Peptide-Drug Conjugates(PDCs) CDMO Service Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. WUXIAPP Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 47. Medicilon Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 48. Creative Peptides Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 49. Peptistar Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 50. BOCSCI Inc Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 51. HUATENG PHARMA Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 52. CPC Scientific Inc Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 53. Porton Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 54. VIVA Biotech Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 55. Taichu Group Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 56. PharosGen Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 57. CENTER LABORATORIES, INC Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 58. JIUZHOU Pharmaceutical Revenue Growth Rate in Peptide-Drug Conjugates(PDCs) CDMO Service Business (2019-2024)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Peptide Drug CDMO Market Research Report 2024

Global Antibody Drug Conjugate CDMO Market Research Report 2024

Peptide CDMO Pharmaceutical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Peptide Synthesis CDMO Services Market Research Report 2024

Global Antibody drug Conjugates ADCs CMO and CDMO Market Research Report 2025

Global Peptide API CDMO Services Market Research Report 2025

Global ADC Drug CDMO Service Market Research Report 2024

Global Custom Peptide CDMO Services Market Research Report 2024

Global PPMO Peptide PMO Conjugates Therapy Market Research Report 2024

Global Peptide PMO Conjugates PPMO Market Research Report 2024

Global Oligonucleotide Drug CDMO Services Market Research Report 2024

Global Cellular and Gene Therapy CDMO Market Research Report 2025

Small Molecule Drug CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Biologics CDMO Services Market Research Report 2024

Global Cell and Gene Therapy CDMO Services Market Research Report 2024

Global Pharmaceutical CDMO Market Research Report 2025

Global Large Molecule Drug Substance CDMO Market Research Report 2024

Pharmaceutical CMO and CDMO Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Antibody Oligonucleotide Conjugates AOC Drug CDMO Market Research Report 2024

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Y6812

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-34O3983

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-9V17601

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-22C17047

Fri Sep 12 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions